CATEGORICAL COURSES .
.
'·.Dialysis
4. Explain the common pitfalls and artifacts encountered with MRA. 5. Determine the future diagnostic and therapeutic directions of vascular MRI. 7:30 a.m.
Friday, March 28, 2003 7:30 a.m.-9:30 a.m. Coordinator/Moderator: Anne C. Robelts, MD
"Basic Principies oj Contrast Enhanced MRA " Maltin R. Prince, MD 7:45 a.m.
"Clinical Applications oj Carotid and Thoracic J1.1RA"
Objectives: 1. Describe how a dialysis fistula is surgically created. 2. Trace the role of thrombolytic devices in the therapy of thrombosed dialysis fistulas. 3. Articulate the role of thrombolysis in the therapy of thrombosed dialysis fistulas.
Steven Wolff, MD
7:30 a.m.
"5urveillance jor Dialysis Fistulas" Jan Namyslowski, MD
"Clinical Applications oj Peripheral Lower Extremity MRA " Barry Stein, MD
7:50 a.m.
8:45 a.m.
"5urgical Approach to Placement oj Dialysis Fistulas" Erik Owens, MD
"Common Piljalls and Artifacts Encountered with MRA" Neil Rofsky, MD
8:10 a.m.
9:00 a.m.
"Radiological Evaluation oj A Fai/ing Dialysis Fistula" Thomas B. Kinney, MD, MSSME
"Clinical Applications ojMRV" Barry Stein, MD
8:30 a.m.
"Future Directions oj Diagnostic and Therapeutic Vascular MRl" Reed A. Omary, MD
"Thrombolysis in Fistulas" Karim Valji, MD
8:05 a.m.
"Clinical Applications oj Renal and Mesenteric MRA" Maltin R. Prince, MD 8:25 a.m.
9:10 a.m.
8:50 a.m.
"Thrombectomy Devices- What is the Role in Dialysis Fistulas?" Brian F. Stainken, MD 9:10 a.m.
'iWy Approach to the Maljunctioning Dialysis Fistula" Luc Turmel-Rodrigues, MD
MR Angiography
Friday, March 28, 2003 7:30 a.m.-9:30 a.m. Coordinator / Moderator: Barry Stein, MD Objectives: 1. Cite the basic principles of contrast enhanced MRA. 2. Appraise MRA as a powerful clinical toGI in the delivery of diagnostic and therapeutic vascular care. 3. Describe the common clinical vascular applications of MRA and MRV.
Oncology Friday, March 28, 2003 10:00 a.m.-12:00 p.m. Coordinator/Moderator: Riad Salem, MD, MBA Objectives: 1. Explain basic principles of hepatic artery chemoembolization, including pre-treatment evaluation, procedural issues and management, and post-treatment follow-up. 2. Describe the role of radioactive microspheres in the treatment of hepatic malignancies. 3. Discuss new therapies in head and neck cancer. 10:00 a.m.
"Therapy jor Liver Cancer by Targeting Energy Metabolism " Jeff H. Geschwind, MD 10:20 a.m.
'Jl1ultimodality Image-Guided Therapy jor Liver Tu mors " Michael C. Soulen, MD P175